Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Application of mass spectrometry to the discovery of biomarkers for detection of prostate cancer.

Semmes OJ, Malik G, Ward M.

J Cell Biochem. 2006 Jun 1;98(3):496-503. Review.

PMID:
16552720
[PubMed - indexed for MEDLINE]
2.

Proteomics for the identification of new prostate cancer biomarkers.

Ornstein DK, Tyson DR.

Urol Oncol. 2006 May-Jun;24(3):231-6. Review.

PMID:
16678055
[PubMed - indexed for MEDLINE]
3.

Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.

Bakry R, Rainer M, Huck CW, Bonn GK.

Anal Chim Acta. 2011 Mar 25;690(1):26-34. doi: 10.1016/j.aca.2011.01.044. Epub 2011 Mar 2. Review.

PMID:
21414433
[PubMed - indexed for MEDLINE]
4.

New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics.

Paweletz CP, Liotta LA, Petricoin EF 3rd.

Urology. 2001 Apr;57(4 Suppl 1):160-3.

PMID:
11295617
[PubMed - indexed for MEDLINE]
5.

A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.

Yasui Y, Pepe M, Thompson ML, Adam BL, Wright GL Jr, Qu Y, Potter JD, Winget M, Thornquist M, Feng Z.

Biostatistics. 2003 Jul;4(3):449-63.

PMID:
12925511
[PubMed - indexed for MEDLINE]
Free Article
6.

MALDI mass spectrometry in prostate cancer biomarker discovery.

Flatley B, Malone P, Cramer R.

Biochim Biophys Acta. 2014 May;1844(5):940-9. doi: 10.1016/j.bbapap.2013.06.015. Epub 2013 Jul 2. Review.

PMID:
23831156
[PubMed - indexed for MEDLINE]
7.

[Surface enhanced laser desorption/ionization (SELDI): proteomics technology and its application in oncology].

Espejel F, Roa JC.

Med Clin (Barc). 2008 Sep 13;131(8):312-7. Review. Spanish.

PMID:
18803927
[PubMed - indexed for MEDLINE]
8.

Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery.

Seibert V, Ebert MP, Buschmann T.

Brief Funct Genomic Proteomic. 2005 May;4(1):16-26. Review.

PMID:
15975261
[PubMed - indexed for MEDLINE]
Free Article
9.

[Proteomic analysis of prostate cancer using surface enhanced laser desorption/ionization mass spectrometry].

Pan YZ, Xiao XY, Zhao D, Zhang L, Ji GY, Li Y, He DC, Zhao XJ, Yang BX.

Zhonghua Yi Xue Za Zhi. 2005 Nov 30;85(45):3172-5. Chinese.

PMID:
16405834
[PubMed - indexed for MEDLINE]
10.

Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.

Fredolini C, Liotta LA, Petricoin EF.

Crit Rev Clin Lab Sci. 2010 May-Jun;47(3):125-38. doi: 10.3109/10408363.2010.503558. Epub 2010 Sep 21. Review.

PMID:
20858067
[PubMed - indexed for MEDLINE]
11.

Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry.

Engwegen JY, Gast MC, Schellens JH, Beijnen JH.

Trends Pharmacol Sci. 2006 May;27(5):251-9. Epub 2006 Apr 4. Review.

PMID:
16600386
[PubMed - indexed for MEDLINE]
12.

SELDI-TOF proteomic analysis and cancer detection.

Henderson NA, Steele RJ.

Surgeon. 2005 Dec;3(6):383-90, 422. Review.

PMID:
16353858
[PubMed - indexed for MEDLINE]
13.

Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry.

Hu S, Yu T, Xie Y, Yang Y, Li Y, Zhou X, Tsung S, Loo RR, Loo JR, Wong DT.

Cancer Genomics Proteomics. 2007 Mar-Apr;4(2):55-64.

PMID:
17804867
[PubMed - indexed for MEDLINE]
Free Article
14.

A robust meta-classification strategy for cancer detection from MS data.

Bhanot G, Alexe G, Venkataraghavan B, Levine AJ.

Proteomics. 2006 Jan;6(2):592-604.

PMID:
16342141
[PubMed - indexed for MEDLINE]
15.

Proteomics in the analysis of prostate cancer.

Naaby-Hansen S, Nagano K, Gaffney P, Masters JR, Cramer R.

Methods Mol Med. 2003;81:277-97. No abstract available.

PMID:
12725127
[PubMed - indexed for MEDLINE]
16.

An introduction into proteomics and its clinical applications.

Ahram M.

Saudi Med J. 2007 Apr;28(4):499-507. Review.

PMID:
17457467
[PubMed - indexed for MEDLINE]
17.

Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes OJ, Schellhammer PF, Yasui Y, Feng Z, Wright GL Jr.

Cancer Res. 2002 Jul 1;62(13):3609-14.

PMID:
12097261
[PubMed - indexed for MEDLINE]
Free Article
18.

Application of proteomic strategies to the identification of urinary biomarkers for prostate cancer: a review.

Downes MR, Byrne JC, Dunn MJ, Fitzpatrick JM, Watson RW, Pennington SR.

Biomarkers. 2006 Sep-Oct;11(5):406-16. Review.

PMID:
16966158
[PubMed - indexed for MEDLINE]
19.

Peptide and protein imaging mass spectrometry in cancer research.

McDonnell LA, Corthals GL, Willems SM, van Remoortere A, van Zeijl RJ, Deelder AM.

J Proteomics. 2010 Sep 10;73(10):1921-44. doi: 10.1016/j.jprot.2010.05.007. Epub 2010 May 25. Review.

PMID:
20510389
[PubMed - indexed for MEDLINE]
20.

Proteomics in prostate cancer biomarker discovery.

Larkin SE, Zeidan B, Taylor MG, Bickers B, Al-Ruwaili J, Aukim-Hastie C, Townsend PA.

Expert Rev Proteomics. 2010 Feb;7(1):93-102. doi: 10.1586/epr.09.89. Review.

PMID:
20121479
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk